Bloomberg Financial Accounting News Shares Mutarelli’s Post-Q3 Results

In the November issue, Bloomberg publishes Mutarelli’s third-quarter analysis results of valuations and impairment testing, including potential goodwill impairment.

COVID & U.S. Portfolio Securities Valuation: An update on credit spreads and required returns

In Q3 2020, secondary equity and credit markets rebounded, primary equity and levered finance markets reopened, and the price of risk declined.

Jason Mutarelli Published in Bloomberg Tax

Featured in the October issue, Mutarelli analyzes how to approach valuations and impairment testing when managing through the impacts of COVID.

Private Equity & Debt Capital Markets Adjust to the New Normal

As we head into Q4 2020, the new normal in private capital markets has fully set in, generally defined by prudence and caution, albeit a work in progress.

Impairment Barometer: Update Aug. 31, 2020

Observations and measures of how COVID-related events through August 31, 2020, have impacted equity market indices, adjustments to EBITDA expectations, and their influence on enterprise values by sector.

Q2 2020 Economic Snapshots

Quick-hit visual summaries of the leading economic and financial indicators in major economic markets.

Impairment Barometer

Observations and measures of how H1 2020 COVID-related events have impacted equity market indices, adjustments to EBITDA expectations, and their influence on enterprise values by sector.

COVID-19: Event Timeline (Updated June 2020)

VRC continues to identify potential triggering events of the health and financial crisis as we help clients with financial reporting in our preparation of valuations.

Avoiding Valuation Surprises in M&A

Not every company uses the same method for valuation. Recently, VRC and one of its key partners shared insight into their valuation “secret sauce.”

COVID-19: Event Timeline

Tracking the socioeconomic disruption of the coronavirus pandemic.